Unibest
← Back to patent-cliff list

CAS 79-30-1

isobutyryl chloride2-Methylpropanoyl chloride2-Methylpropionyl chlorideIsobutyryl chloride

Codes: ATOR-004, (VIa)1140100-1-a, (IIb)1140100-3-a, Molnupiravir-016, CICL-015

Application context (from source-drug indications)

Type 2 diabetesAtorvastatin Calcium Hydrate/Metformin HydrochlorideHyperlipidaemiaAtorvastatin Calcium Hydrate/Metformin HydrochlorideHypertensionAtorvastatin Calcium Hydrate/IrbesartanHyperlipidaemiaAtorvastatin Calcium Hydrate/IrbesartanHypercholesterolaemiaAtorvastatin Calcium Hydrate/RamiprilHypertensionAtorvastatin Calcium Hydrate/RamiprilHyperlipoproteinaemia type IIIAtorvastatin Calcium HydrateHyperlipidaemiaAtorvastatin Calcium HydrateHeterozygous familial hypercholesterolaemiaAtorvastatin Calcium HydrateHeart failureAtorvastatin Calcium HydrateType 2 diabetesAtorvastatin Calcium HydrateStrokeAtorvastatin Calcium HydrateCOVID-19Deuremidevir hydrobromide呼吸道合胞体病毒感染Deuremidevir hydrobromide亨尼波病毒属感染Deuremidevir hydrobromideCOVID-19Molnupiravir呼吸道合胞体病毒感染MolnupiravirInfluenza virus infectionMolnupiravirRenal impairmentMolnupiravirHepatic function declineMolnupiravirAsthmaCiclesonidePerennial allergic rhinitisCiclesonideSeasonal allergic rhinitisCiclesonideAllergic rhinitisCiclesonide支气管肺发育不良CiclesonideCOVID-19Ciclesonide

Source drugs (routes using this intermediate)

DrugTierExpiry
Atorvastatin Calcium Hydrate/Metformin HydrochlorideTier C — Watch / trade-
Atorvastatin Calcium Hydrate/IrbesartanTier C — Watch / trade-
Atorvastatin Calcium Hydrate/RamiprilTier C — Watch / trade-
Atorvastatin Calcium HydrateTier B — Position early-
Deuremidevir hydrobromideTier C — Watch / trade-
MolnupiravirTier B — Position early-
CiclesonideTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Deuremidevir hydrobromideOptimised routesteps: 7total yield: /
(2R,3R,4R,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carbonitrile→(2R,3R,4R,5R)-2-(4-Amino-5-iodopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-[(benzyloxy)methyl]oxolane-2-carbonitrile→(2R,3R,4R,5R)-2-[4-Amino-5-deuteropyrrolo[2,1-f][1,2,4]triazin-7-yl]-3,4-bis(benzyloxy)-5-[(benzyloxy)methyl]oxolane-2-carbonitrile→(2R,3R,4S,5R)-2-(4-Amino-5-deuteriopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile→N'-[7-[(2R,3R,4S,5R)-2-Cyano-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-deuteropyrrolo[2,1-f][1,2,4]triazin-4-yl]-N,N-dimethylmethanimidamide→2-Methylpropanoyl chloride→2-Methylpropanoyl 2-methylpropanoate→(2R,3R,4R,5R)-2-Cyano-2-[4-[(Z)-[(dimethylamino)methylidene]amino]-5-deuteropyrrolo[2,1-f][1,2,4]triazin-7-yl]-5-[[(2-methylpropanoyl)oxy]methyl]oxolane-3,4-diyl bis(2-methylpropanoate)→(2R,3R,4R,5R)-2-[4-Amino-5-deuteropyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-cyano-5-[[(2-methylpropanoyl)oxy]methyl]oxolane-3,4-diyl bis(2-methylpropanoate)
Deuremidevir hydrobromideOptimised routesteps: 3total yield: /
(2R,3R,4S,5R)-2-(4-Amino-5-bromopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile→(2R,3R,4S,5R)-2-(4-Amino-5-deuteriopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile→(2R,3R,4S,5R)-2-[4-Amino-5-deuteropyrrolo[2,1-f][1,2,4]triazin-7-yl]-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile hydrogen chloride→2-Methylpropanoyl 2-methylpropanoate→2-Methylpropanoyl chloride→(2R,3R,4R,5R)-2-[5-Bromo-4-(2-methylpropanamido)pyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-cyano-5-[[(2-methylpropanoyl)oxy]methyl]oxolane-3,4-diyl bis(2-methylpropanoate)→(2R,3R,4R,5R)-2-Cyano-2-[4-(2-methylpropanamido)-5-deuteropyrrolo[2,1-f][1,2,4]triazin-7-yl]-5-[[(2-methylpropanoyl)oxy]methyl]oxolane-3,4-diyl bis(2-methylpropanoate)
MolnupiravirOptimised routesteps: 12total yield: /
Molnupiravir-012→Methyl 2,3-O-isopropylidene-beta-D-ribofuranoside→Methyl 5-O-benzoyl-2,3-O-(1-methylethylidene)-beta-D-ribofuranoside→1,2,3-Tri-O-acetyl-5-O-benzoyl-beta-D-ribofuranose→2-Methylpropionyl chloride→N-(2-Oxo-1,2-dihydropyrimidin-4-yl)acetamide→N-Acetyl-2',3'-di-O-acetyl-5'-O-benzoylcytidine→Cytosine-1-beta-D-ribofuranoside→Sulfuric acid 2',3'-O-(1-methylethylidene)cytidine→2',3'-O-(1-Methylethylidene)cytidine→2',3'-O-(1-Methylethylidene)-N-(2-methylpropanoyl)-5'-O-(2-methylpropanoyl)cytidine→Hydroxylamine→Hydroxylamine hydrochloride→Hydroxylamine sulfate→N-Hydroxy-2',3'-O-(1-methylethylidene)-5'-O-(2-methylpropanoyl)cytidine→2-Methylpropionic anhydride
MolnupiravirOptimised routesteps: 2total yield: /
MolnupiravirOptimised routesteps: 6total yield: 5.14g(Molnupiravir)
N-[(Dimethylamino)methylidene]cytidine→5'-O-(2-Methylpropanoyl)cytidine oxalate→N,O2',O3'-Tris[(dimethylamino)methylidene]cytidine→1-(beta-D-Ribofuranosyl)cytosine→Acetone O-isobutyryloxime→Isobutyryl chloride→2-Methylpropionic acid→5'-O-Isobutyryl cytidine→Dimethylacetic anhydride
MolnupiravirOptimised routesteps: 5total yield: /
2,3-O-Isopropylidene-D-ribofuranose→2,3-O-(1-Methylethylidene)-1,5-bis-O-(2-methylpropanoyl)-D-ribofuranose→4-Aminopyrimidin-2(1H)-one→2',3'-O-(1-Methylethylidene)-5'-O-(2-methylpropanoyl)cytidine→Molnupiravir-052→Isobutyryl chloride
CiclesonideOptimised routesteps: 3total yield: /
cyclohexanecarbaldehyde→(6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one→(8S,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-13-methyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one→sodium cyclohexyl(hydroxy)methanesulfonate→isobutyryl chloride

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Taizhou GMP-like Site((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.